Final report (A) Cardiovascular surgery
First, we are very pleased with the high response rate to our survey of cardiovascular surgery (99.0 %), which definitely enhances the quality of this annual report. We very much appreciate the enormous effort put into completing the survey at each participating institution. Figure 1 shows the development of cardiovascular surgery in Japan over the last 25 years. Aneurysm surgery includes only operations for thoracic or thoracoabdominal aortic aneurysms. The number of pacemaker and assist device implantation operations is not included in the total number of surgical operations. A total of 59,302 cardiovascular operations were performed at 586 institutions during 2010 alone and included 21 cardiac transplantations, which were started from 1999. The number of operations for thoracic aortic aneurysm consistently increased, by 6.3 %, and that for valvular heart disease also increased, by 9.5 %, compared with 2009. Surgery for congenital heart disease slightly increased, by 1.9 %. By contrast, the number of operations for ischemic heart disease decreased by 6.1 % in 2010 compared with 2009.
Data for individual categories are summarized in Tables 1, 2 , 3, 4, 5, 6 and 7. In 7, 197 open-heart operations performed for congenital heart disease, the overall hospital mortality was 2.7 %, which has varied little since 2005. Mitral valve repair constituted 28.7 % of all valvular heart disease operations (18, 713) , which is similar to that of the last 3 years. Aortic valve replacement with a bioprosthesis was performed in 7,016 cases, with the number consistently increasing. The hospital mortality rates associated with primary single valve replacement were 2.7 and 5.7 % for aortic and mitral valve replacement, respectively, while that for primary mitral valve repair was 1.2 %. However, hospital mortality rates for redo valve surgery were 5.9 and 11.1 % for aortic and mitral procedures, respectively.
Isolated coronary artery bypass grafting (CABG) was performed in 15,521 cases which is an decrease of 6.1 % compared with 16,536 in 2009.
The operative and hospital mortality rates associated with primary elective CABG procedures in 13,238 cases were 0.7 and 1.2 %, respectively. However, hospital mortality of primary emergency CABG in 2,236 cases was 7.4 %, which was still high. Off-pump coronary bypass grafting (OPCAB) was performed in 9,510 cases, constituting 61.3 % of the total isolated CABG procedures. The percentage of OPCAB cases among the total isolated CABG procedures has been at the same level since 2005.
A total of 1,409 patients underwent surgery for complications of myocardial infarction, including 416 operations for a left ventricular aneurysm or infarction and 472 operations for ischemic mitral regurgitation. Operations for thoracic aortic dissection were performed in 5,473 cases. For 3,687 type A acute aortic dissections, hospital mortality was 11.1 %, which was similar to that in 2009 (12.7 %) . Operations for a non-dissected thoracic aneurysm were carried out in 7,241 cases, with an overall hospital mortality of 6.3 %, which was same level as 6.4 % in 2009. The hospital mortality associated with unruptured aneurysms was 4.2 %, and that for ruptured aneurysms was 24.6 %, which remains markedly high. The number of stent graft procedures remarkably increased. A total of 684 patients with aortic dissection underwent stent graft placement: transluminal stent grafting (TEVAR) in 211 cases, open stent grafting in 118 cases. The hospital mortality rates associated with TEVAR for type B aortic dissection were 10.7 and 3.0 %, for acute and chronic cases, respectively. A total of 3,025 patients with a non-dissected aortic aneurysm underwent stent graft placement, which increased 2 times that in 2009. The hospital mortality rates for TEVAR were 2.6 and 18.2 % for nonruptured and ruptured aneurysms, respectively.
In summary, the total cardiovascular operations increased during the year 2010 by 1,484 cases. They were performed with steadily improving results in almost all categories compared with those in 2009. Table 1 Congenital (total; 9,558) (1) CPB (?) (total; 7,197 (b) Off-pump CABG (total; 9,510) (The present section also includes cases of planned off-pump CABG in which, during surgery, the change is made to an on-pump CABG or on-pump beating-heart procedure) Values in parenthesis represent mortality % The total number of operations reported in 2010 in general thoracic surgery has reached 67,960. This is due to the steady increase in lung cancer surgery as last year (31,301; 2009, 32,801; 2010) . Surgery for lung cancer consists more than 48 % of all the general thoracic surgery. Lung cancer is the biggest health problem of Japan. Among lung cancer subtypes, adenocarcinoma consists an overwhelming percentage of 68.6 % of the total lung cancer surgery. However, this figure has not changed since 2008; the trend of increasing frequency of adenocarcinoma seems to have plateaued (67.9 %; 2009). More and more lung cancer surgeries are being done using video assisted thoracic surgery (VATS) and now exceed 50 % of lung cancer surgery (59.6 %; 2010). The 30-day mortality of lung cancer patients undergoing lobectomy is as low as 0.4 % (0.4; 2009). Pneumonectomy was done in 606 patients with a hospital death of 1.8 (3.6 %; 2009) %. The number of sleeve lobectomy has plummeted (441;2009, 400;2010) .
The top five reasons for 30 days death after lung resection for lung cancer remain same in these four years regardless of order (interstitinal pneumonia, cardiovascular event, pneumonia, bronchopleural fistulas and respiratory failure). The analyses of cardiovascular event after lung resection have been done in the 29th annual meeting of Japanese Association for Chest Surgery and further investigation will be done in the next annual meeting.
6,748 patients with metastatic pulmonary tumor were operated in 2010, a 8.8 % increase from the previous year. 72 % of these were operated using VATS. (Tables 1, 2 , 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25) . Tables 3, 4 ). The decrease of registered patients with surgically treated benign esophageal diseases is obvious, and this decrease of registered benign esophageal diseases with operation for these few years might show that the more number of such patients are treated in medical departments. The patients registered, particularly those undergoing nonsurgical therapy for a malignant esophageal disease, have been increasing since 1990 (Fig. 1) . Among benign esophageal diseases (Table 2) , esophageal varices, esophagitis (including reflux esophagitis) and hiatal hernia were the most common conditions in Japan. On the other hand, achalasia, benign esophageal tumors, spontaneous rupture of the esophagus, and congenital esophageal atresia were common diseases which were surgically treated as well as the above-mentioned diseases. The thoracoscopic and/or laparoscopic procedures have been widely adopted for benign esophageal diseases, in particular achalasia, hiatal hernia and benign tumors. Open surgery was performed in 365 patients with a benign esophageal disease, with 30-day mortality in 8 (2.2 %) and with hospital mortality including 30-day mortality in 16 (4.4 %), while thoracoscopic and/or laparoscopic surgery was performed for 467 patients, with 2 of the 30-day mortality and 2 (0.4 %) of the hospital mortality. The difference in these death rates between open and scopic surgery seems to be related the conditions requiring open surgery. Most of the death was found in the patients with spontaneous esophageal rupture, which required open surgery.
The majority of malignant diseases were carcinomas (Table 3) . Among esophageal carcinomas, the incidence of squamous cell carcinoma was 93.0 %, while that of adenocarcinomas including Barrett cancer was 4.6 %. The resection rate for patients with a squamous cell carcinoma was 70.0 %, while that for patients with an adenocarcinoma was 87.4 %.
According to location, cancer in the thoracic esophagus was the most common (Table 4) . Of the 3,396 patients (34.7 % of total esophageal malignancies) having superficial esophageal cancers within mucosal and submucosal layers, 1,474 (43.4 %) patients underwent esophagectomy, while 1,630 (48.0 %) patients underwent EMR or ESD. The 30-day mortality rate and hospital mortality rate after esophagectomy for patients with a superficial cancer were 0.5 and 1.0 %, respectively. There was no EMR or ESD-related death. Advanced esophageal cancer invading deeper than the submucosal layer was observed in 6,205 (63.5 %) patients. Of the 6,205 patients with advanced esophageal cancer, 3,693 (59.5 %) underwent esophagectomy, with 1.0 % of the 30-day mortality rate, and with 3.3 % of the hospital mortality rate.
Multiple primary cancers were observed in 1,504 (15.4 %) of all the 9,777 patients with esophageal cancer. Synchronous cancer was found in 777 (51.7 %) patients, while metachronous cancer (found before esophageal cancer) was observed in 727 (48.3 %) patients. The stomach is the commonest site for both synchronous and metachronous malignancy followed by head and neck cancer (Table 4) .
Among esophagectomy procedures, transthoracic esophagectomy through right thoracotomy was the most commonly adopted for patients with a superficial cancer as well as for those with an advanced cancer (Table 5) . Transhiatal esophagectomy commonly performed in Western countries was adopted in only 3.9 % of patients having a superficial cancer who underwent esophagectomy and in 1.9 % of those having an advanced cancer in Japan. The thoracoscopic and/or laparoscopic esophagectomy were adopted for 556 patients (37.7 %) with a superficial cancer, and for 660 patients (17.9 %) with an advanced cancer. The number of cases of thoracoscopic and/or laparoscopic surgery for superficial or advanced cancer has been increasing for several years (Fig. 2) .
Combined resection of the neighboring organs during resection of an esophageal cancer was performed in 338 patients (Tables 5, 6 ). Resection of the aorta together with the esophagectomy was performed in 2 cases. Tracheal and/or bronchial resection combined with esophagectomy was performed in 33 patients, with the 30-day mortality rate at 0 % and the hospital mortality rate at 3.0 %. Lung resection combined with esophagectomy was performed in 58 patients, with the 30-day mortality rate at 0 % and the hospital mortality rate at 0 %. Salvage surgery after definitive (chemo-) radiotherapy was performed in 169 patients, with the 30-day mortality rate at 1.8 % and with the hospital mortality rate at 8.3 % (Table 5) .
Lastly, in spite of the efforts of the Committee to cover wider patient populations to this annual survey, the majority of the institutions which responded to the questionnaire were the departments of thoracic or esophageal surgery. It should be noted that larger number of patients with esophageal diseases should have been treated medically and endoscopically. We should continue our effort for complete survey through more active collaboration with the Japan Esophageal Society and other related societies. 
